Mid Atlantic Financial Management’s GSK GSK Stock Holding History

Mid Atlantic Financial Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$256K	Sell	5,365 -344	-6%	-$17.3K	0.02%	728
2021 Q2	$284K	Sell	5,709 -1,635	-22%	-$78.6K	0.02%	689
2021 Q1	$328K	Sell	7,344 -1,950	-21%	-$88.5K	0.02%	590
2020 Q4	$427K	Sell	9,294 -70	-0.7%	-$3.21K	0.03%	439
2020 Q3	$439K	Buy	9,364 +1,573	+20%	+$78.8K	0.04%	393
2020 Q2	$397K	Sell	7,791 -1,110	-12%	-$56.9K	0.04%	399
2020 Q1	$422K	Sell	8,901 -3,454	-28%	-$184K	0.05%	348
2019 Q4	$726K	Sell	12,355 -805	-6%	-$44.8K	0.07%	297
2019 Q3	$702K	Sell	13,160 -1,862	-12%	-$95.8K	0.07%	276
2019 Q2	$752K	Buy	15,022 +1,015	+7%	+$50.9K	0.08%	274
2019 Q1	$732K	Buy	14,007 +123	+0.9%	+$6.15K	0.08%	269
2018 Q4	$663K	Buy	+13,884	New	+$684K	0.08%	253

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mid Atlantic Financial Management's GSK Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its GSK (GSK) stake by 6% in Q3 2021, selling an estimated $17.3K and leaving 5,365 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #728.

Mid Atlantic Financial Management first reported a position in GSK in Q4 2018 and has held it in 12 quarters since. The position peaked at $752K in Q2 2019. 793 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

Mid Atlantic Financial Management held 5,365 shares of GSK worth $256K as of Q3 2021.
Mid Atlantic Financial Management sold 344 GSK shares in Q3 2021, an estimated $17.3K.
GSK made up 0.02% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #728 holding.
Mid Atlantic Financial Management first reported a position in GSK in Q4 2018 and has held it in 12 quarters since.
Mid Atlantic Financial Management's GSK position peaked at $752K in Q2 2019.
793 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.